should i switch from semaglutide to tirzepatide Switching Officially made the switch from

The combination of metformin and GLP-1 RA is explicitly recommended by current guidelines as part of the standard treatment algorithm for type 2 diabetes, wi...

Large study hints GLP-1 medicines may reduce substance-use disorders

Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies raise questions.

The strong Ozempic brand is set to revitalize an older tablet, as Novo Nordisk steps up its competition against Eli Lilly.

Common side effects of dulaglutide include nausea, diarrhea, and abdominal distension, and these are usually mild to moderate in severity and tend to diminish over time